Oxygen Biotherapeutics Inc (NASDAQ:OXBT)

Data as of Sep 16
 +0.04 / +0.99%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Oxygen Biotherapeutics, Inc. engages in developing biotechnology products, which focuses on oxygen delivery to specific target tissues. The company has developed a proprietary perfluorocarbon therapeutic oxygen carrier called Oxycyte that is currently in clinical and preclinical studies for intravenous delivery for indications such as traumatic brain injury, decompression sickness and stroke. It is also developing PFC-based creams and gels for topical delivery to the skin for dermatologic conditions and potentially wound care. In addition, the company has commercialized its Dermacyte line of skin care cosmetics for the anti-aging market. Oxygen Biotherapeutics was founded on May 26, 1967 and is headquartered in Morrisville, NC.

Contact Information

Oxygen Biotherapeutics, Inc.
One Copley Parkway
Morrisville North Carolina 27560
P:(919) 855-2100
Investor Relations:
(919) 855-2112



Other institutional32.61%
Individual stakeholders1.52%
Mutual fund holders1.06%

Top Executives

John P. KelleyChief Executive Officer & Director
Michael B. JebsenChief Financial Officer & Treasurer
Timothy BradshawExecutive Vice President-Clinical Development
Charles L. PamplinChief Medical Officer
Doug RandallExecutive VP-Business & Commercial Operations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.